
Natco Pharma, a pharmaceutical company based in Hyderabad, has reported a significant increase in its consolidated net profit for the second quarter of the fiscal year 2023-24. The company's net profit grew by 547% to reach Rs 369 crore, while its total revenue saw a 134% increase to reach Rs 1,061 crore. The growth was attributed to an increase in formulations exports and sales in the domestic agrochemical business. The company also declared a second interim dividend for the fiscal year 2024.